Context Therapeutics, Inc. (CNTX)
0.3042
+0.01
(+1.74%)
USD |
NASDAQ |
Oct 09, 16:00
0.29
-0.01
(-4.67%)
After-Hours: 20:00
Context Therapeutics EPS Diluted (Quarterly) : -0.153 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.153 |
| March 31, 2026 | -0.0912 |
| December 31, 2025 | -0.1418 |
| September 30, 2025 | -0.1018 |
| June 30, 2025 | -0.0927 |
| March 31, 2025 | -0.0481 |
| December 31, 2024 | -0.0373 |
| September 30, 2024 | -0.2169 |
| June 30, 2024 | -0.041 |
| March 31, 2024 | -0.2297 |
| December 31, 2023 | -0.424 |
| September 30, 2023 | -0.368 |
| June 30, 2023 | -0.3139 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.3951 |
| December 31, 2022 | -0.2228 |
| September 30, 2022 | -0.2414 |
| June 30, 2022 | -0.2497 |
| March 31, 2022 | -0.2154 |
| December 31, 2021 | -0.1936 |
| September 30, 2021 | -0.1316 |
| June 30, 2021 | -0.459 |
| March 31, 2021 | -0.0814 |
| September 30, 2020 | -0.0799 |
| June 30, 2020 | 0.6824 |
| March 31, 2020 | 0.0754 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -0.5405 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.56M |
| Total Expenses (Quarterly) | 14.56M |
| Enterprise Value | -14.80M |
| Earnings Yield | -160.4% |
| Normalized Earnings Yield | -160.36 |